T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$2.18B |
| 2 |
Airbnb
ABNB
|
+$1.59B |
| 3 |
Goldman Sachs
GS
|
+$1.35B |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.27B |
| 5 |
Caterpillar
CAT
|
+$1.24B |
Top Sells
| 1 |
Apple
AAPL
|
+$2.44B |
| 2 |
Qualcomm
QCOM
|
+$1.64B |
| 3 |
Becton Dickinson
BDX
|
+$1.61B |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.43B |
| 5 |
Fidelity National Information Services
FIS
|
+$1.04B |
Sector Composition
| 1 | Technology | 25.04% |
| 2 | Healthcare | 16.2% |
| 3 | Consumer Discretionary | 15.91% |
| 4 | Financials | 12.32% |
| 5 | Communication Services | 11.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Realty Income
O
$55.1B
| $47.9M | ﹤0.01% |
795,667
-5,216
| -0.7% | -$314K |
|
977
Albany International
AIN
$1.73B
| $47.3M | ﹤0.01% |
644,687
+13,076
| +2% | +$960K |
|
978
Amicus Therapeutics
FOLD
$2.44B
| $47.3M | ﹤0.01% |
2,049,362
+858,025
| +72% | +$19.8M |
|
979
ProAssurance
PRA
$1.22B
| $47M | ﹤0.01% |
2,639,380
+180,849
| +7% | +$3.22M |
|
980
Ingevity
NGVT
$2.08B
| $46.9M | ﹤0.01% |
619,398
-29,773
| -5% | -$2.25M |
|
981
Walker & Dunlop
WD
$2.89B
| $46.7M | ﹤0.01% |
507,161
+54,104
| +12% | +$4.98M |
|
982
Onto Innovation
ONTO
$5.83B
| $46.7M | ﹤0.01% |
981,153
-54,771
| -5% | -$2.6M |
|
983
Insperity
NSP
$1.96B
| $46.5M | ﹤0.01% |
570,930
+2,377
| +0.4% | +$194K |
|
984
Stoke Therapeutics
STOK
$1.28B
| $46.4M | ﹤0.01% |
749,626
+379,533
| +103% | +$23.5M |
|
985
Seres Therapeutics
MCRB
$144M
| $46.1M | ﹤0.01% |
94,163
+65,055
| +223% | +$31.9M |
|
|
ACBI
986
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $46.1M | ﹤0.01% |
2,893,573
-176,829
| -6% | -$2.82M |
|
987
Service Corp International
SCI
$11.2B
| $46M | ﹤0.01% |
936,805
-340,454
| -27% | -$16.7M |
|
988
Nexstar Media Group
NXST
$6.15B
| $45.7M | ﹤0.01% |
418,520
-76,185
| -15% | -$8.32M |
|
|
DRNA
989
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $45.7M | ﹤0.01% |
2,072,217
-21,461
| -1% | -$473K |
|
990
EXL Service
EXLS
$6.85B
| $45.6M | ﹤0.01% |
2,678,010
+25,035
| +0.9% | +$426K |
|
991
CAE Inc
CAE
$8.67B
| $45.5M | ﹤0.01% |
1,644,255
-87,938
| -5% | -$2.43M |
|
|
ABMD
992
DELISTED
Abiomed Inc
ABMD
| $45.5M | ﹤0.01% |
140,378
-2,929
| -2% | -$950K |
|
993
Grocery Outlet
GO
$1.63B
| $45.5M | ﹤0.01% |
1,158,409
+140,798
| +14% | +$5.53M |
|
|
DRE
994
DELISTED
Duke Realty Corp.
DRE
| $45.5M | ﹤0.01% |
1,137,295
+129,680
| +13% | +$5.18M |
|
995
Saic
SAIC
$4.73B
| $45.4M | ﹤0.01% |
479,902
-2,590
| -0.5% | -$245K |
|
996
Kinder Morgan
KMI
$60.6B
| $45.2M | ﹤0.01% |
3,303,472
-168,754
| -5% | -$2.31M |
|
997
Atkore
ATKR
$2.08B
| $44.8M | ﹤0.01% |
1,090,821
-237,103
| -18% | -$9.75M |
|
|
BLUE
998
DELISTED
bluebird bio
BLUE
| $44.7M | ﹤0.01% |
79,811
+5,436
| +7% | +$3.05M |
|
|
REGI
999
DELISTED
Renewable Energy Group, Inc.
REGI
| $44.7M | ﹤0.01% |
631,123
+359,502
| +132% | +$25.5M |
|
1000
OSI Systems
OSIS
$3.97B
| $44.5M | ﹤0.01% |
477,789
-91,775
| -16% | -$8.56M |
|